Indaptus Therapeutics's total assets for Q3 2024 were $8.24M, an increase of 1.45% from the previous quarter. INDP total liabilities were $2.24M for the fiscal quarter, a 14.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.